At Boston Oncology, we support the healthcare of citizens in emerging markets around the world through regional development and production of licensed biopharmaceutical products.

  • What We Do

    We are constructing a broad-based product portfolio of licensed, small-molecule chemotherapies, large protein immune-modulators and co-developed antibody biosimilars, Boston Oncology is a catalyst functioning at the intersection of medicine, research & technology, business and government.

    Learn what we do →

    Research & Technology
  • Partnering for Progress

    We harness the output of our global partners, leading scientific and medical producers, and the commercial infrastructure of our local partners to deliver best-in-class biopharmaceutical drugs to our target markets.

    Learn about our business partners →

  • Bringing the Best in Therapeutic Care

    Our pharmaceutical solutions provide generic and biosimilar drugs to the citizens of emerging nations.

    Explore the science behind our business →

  • Our Commitment to the Developing World

    We believe that, through technology transfer, economic development and social progress go hand in hand.

    Read our view on corporate responsibility →

Value of Generics
Generic drugs are safe, effective, and the answer for millions of  patients in the developing world. Learn why.


Emerging Markets
With nearly half of the world’s people and a booming middle class, emerging markets are taking center stage. Find out more.


The challenge: Replicate a molecule with up to 50,000 atoms, reliably and efficiently. Learn how it’s done.


These globally recognized authorities of medicine and business offer great information. Visit them.